← Eichor
Study identifier: NCT03792919 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Condition: Chronic Hepatitis B  ·  Sponsor: Humanity & Health Medical Group Limited

PhasePhase 4
Planned participants2000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

To Identify the collected cases who can stop NAs safely with satisfactory clinical outcome including sustain viral remission and HBsAg clearance among chronic hepatitis B(CHB) patients.

This description comes directly from the study's public registry record.

Talk to the study team

George Lau, MD  ·  852-28613777  ·  gkklau@netvigator.com

Danny Wang  ·  852-28613777  ·  danny.wang@hnhmgl.com

Always discuss trial participation with your own doctor first.

Locations (1)

Humanity & Health Research CentreHong Kong, Hong Kong SAR, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03792919